Anthropic partially gets a win from their AI copyright case as the judge ruled its AI training is fair use, but claimed that they could be sued for piracy.
Archives
Target Looks to Cut Costs with Factory-to-Customer Shipping Initiative
Target is testing factory-to-customer shipping to lower costs and compete with budget-friendly online retailers.
Ford Issues Major Recall for Lincoln Aviators Due to Loose Rear Window Bars
Ford recalls over 132,000 Lincoln Aviator SUVs due to loose rear window bars that could pose a safety risk.
McDonald's Drops Krispy Kreme Partnership, Citing Unsustainable Costs
McDonald's ends Krispy Kreme partnership due to high costs, pulling doughnuts from menus nationwide by July 2.
Starbucks Introduces Transparent Pricing Model for Add-Ons in App Test
Starbucks updates its pricing for drink add-ons and tests a new app feature to show real-time costs for custom orders.
Latest News
Hong Kong ranks 3rd in global competitiveness in 2025, excelling in government and business efficiency. Discover its economic strengths and investment appeal.
Airlines reroute flights as Iran's missile strike on a U.S. base in Qatar heightens Middle East tensions and disrupts global travel.
Amazon announces a $54 billion UK investment plan, creating thousands of jobs and expanding its operations nationwide.
Novo Nordisk ends partnership with Hims & Hers over concerns about unsafe Wegovy sales and FDA violations.
Media Matters sues the FTC, claiming a probe into ad boycotts of Elon Musk's X is political retaliation for its critical reporting.
Visa wins lawsuit over Vanilla gift card fraud claims, as judge rules risks were reasonably known to consumers.
In 2019, following stints at hedge funds Citadel LLC and Schonfeld Strategic Advisors, Blotnick launched his own fund: Brattle Street Capital LLC, named after the street he grew up on in Cambridge. Everything was going his way—until it wasn't.
Tesla's robotaxi testing in Austin are now getting the attention of federal safety regulators for violating traffic laws.
Novo Nordisk's CagriSema helps patients lose over 20% body weight in late-stage obesity trial.
